Evidence map›Paper›PMID 27642359›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2016

Efficacy of Traditional Chinese Medicine in Xerostomia and Quality of Life during Radiotherapy for Head and Neck Cancer: A Prospective Pilot Study.

Pei-Yu Hsu, Sien-Hung Yang, Ngan-Ming Tsang, Kang-Hsing Fan, Chia-Hsun Hsieh, Jr-Rung Lin, Ji-Hong Hong, Yung-Chang Lin, Hsing-Yu Chen, Cheng-Tao Yang and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Impact of low-level laser therapy on the quality of life of patients with xerostomia undergoing head and neck radiotherapy: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Active Ingredients from Chinese Medicine for Combination Cancer Therapy.International journal of biological sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Pei-Yu HsuDepartment of Traditional Chinese Medicine, Division of Chinese Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan.ORCID 0000-0001-9719-1664
Sien-Hung YangDepartment of Traditional Chinese Medicine, Division of Chinese Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan; School of Chinese Medicine, Chang Gung University, Taoyuan 33302, Taiwan.ORCID 0000-0002-8808-3933
Ngan-Ming TsangSchool of Chinese Medicine, Chang Gung University, Taoyuan 33302, Taiwan; Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan.
Kang-Hsing FanDepartment of Radiation Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan.ORCID 0000-0002-0910-7803
Chia-Hsun HsiehDepartment of Internal Medicine, Division of Hematology-Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan 33302, Taiwan.ORCID 0000-0002-5547-409X
Jr-Rung LinClinical Informatics and Medical Statistics Research Center and Graduate Institute of Clinical Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Ji-Hong HongDepartment of Radiation Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.ORCID 0000-0002-1601-6555
Yung-Chang LinDepartment of Internal Medicine, Division of Hematology-Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Hsing-Yu ChenDepartment of Traditional Chinese Medicine, Division of Chinese Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan.
Cheng-Tao YangDepartment of Traditional Chinese Medicine, Division of Chinese Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan.ORCID 0000-0001-6068-7615
Ching-Wei YangDepartment of Traditional Chinese Medicine, Division of Chinese Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan.
Jiun-Liang ChenDepartment of Traditional Chinese Medicine, Division of Chinese Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan; School of Chinese Medicine, Chang Gung University, Taoyuan 33302, Taiwan.ORCID 0000-0002-9714-2771
Chang Gung University · TWTaoyuan Chang Gung Memorial Hospital · TWLinkou Chang Gung Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xerostomia is one of the most common acute and late complications of radiotherapy for head and neck cancer, and it affects quality of life. We conducted a prospective study to evaluate the efficacy of traditional Chinese medicine (TCM) in toxicities and quality of life during radiotherapy. Head and neck cancer patients who were scheduled for radiotherapy were checked for inclusion/exclusion criteria before enrollment. Patients in the study group (inpatients) were hospitalized in a Chinese medicine ward and received concomitant TCM intervention during radiotherapy, while those in the control group (outpatients) received only conventional cancer treatments at the Western outpatient department. The primary end point was amelioration of postradiotherapy side effects. The secondary end points were quality of life during the cancer therapy and occurrence of adverse events following the TCM treatments. Thirty inpatients and 50 outpatients completed the study. Compared to the control group, those in the TCM group had decreased severity of xerostomia. There was no treatment-related impairment of renal or hepatic function among TCM group. Although better outcomes of social contact, dyspnea, physical and emotional function, and financial problems were found in the TCM group, we need further confirmation about the impact of hospitalization itself on these results.

Identifiers

PMID27642359
PMCPMC5011503
OpenAlexW2515294057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.